U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618260) titled 'SIM0613 in Participants With Advanced Solid Tumors' on May 19.
Brief Summary: This is a multicenter, open-label, first-in-human (FIH) study to evaluate the safety, tolerability, efficacy and pharmacokinetic/pharmacodynamic characteristics of SIM0613 in participants with locally advanced/ metastatic solid tumors. The study starts with a dose escalation part (Part 1) followed by a dose expansion part (Part 2).
Study Start Date: May 15
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Cancer
Intervention:
DRUG: SIM0613
Administered as an intravenous infusion in dosing cycles
DRUG: SIM0613
Administered as an intravenous infus...